Contact

Nasal Sprays & Aseptic Fill Finish

Renaissance has multiple aseptic fill finish lines designed to fill sterile vials and nasal sprays. We also offer multiple fill finish lines for unit & bi-dose nasal sprays as well as multi-dose preserved nasal sprays. We can support clinical through commercial volumes.
Learn More

Nasal Spray Capabilities

Renaissance has multiple lines to support production of unit-dose, bi-dose, and multi-dose nasal sprays. We offer the flexibility to manufacture GMP material from development scale to high throughput commercial lines.
Learn More

Laboratory Support

Renaissance offers chemistry, microbiology and spray testing capabilities to support development and validation of methods as well as release and stability testing of finished products.
Learn More

Pharmaceutical Contract Development & Manufacturing Organization

Renaissance develops and manufactures nasal spray and sterile injectable products to fulfill your patients’ needs.

Your Partner for Nasal Sprays

State-of-the-art laboratory

Cutting edge spray characterization instruments, almost 20 years in nasal experience, and successful commercialization of products for the US and global markets, Renaissance is the “one-stop-shop” for all your nasal spray formulation, development, testing, and commercialization needs.

LEARN MORE

Trusted, Reliable Contract Manufacturing

World-class sterile liquid manufacturing

Renaissance is a global, pure-play contract development and manufacturing organization (“CDMO”) leader with an unparalleled bench-to-shelf service offering for nasal and sterile injectable dosage forms.

LEARN MORE

1979

Where it all started. Paco Packaging & Labs relocates to Paco Way in Lakewood, NJ from Philadelphia, PA.

LEARN MORE
pharmaceutical vials on assembly line
Trusted & Reliable Manufacturing

Our Capabilities Overview

Watch Video

Safety

From the day-to-day safety of our co-workers to the safety of the patients who use the pharmaceuticals we manufacture; Renaissance is focused on improving safety at our facilities every day. We empower all of our employees to identify and correct potential hazards to ensure that we can execute our responsibilities in a safe compliant environment.

View Open Positions

Quality

Ensuring the quality of the products we develop and manufacture is the foundation of our business. Quality is part of every team member’s responsibility at Renaissance. Build a rewarding career and be part of a group of talented individuals that provide reliable high-quality pharmaceuticals.

View Open Positions

Services

As a contract service provider, everything we do at Renaissance is based on meeting and exceeding the expectations of our clients. Our team of dedicated employees implements a service mentality in everything we do.

See Our Services

UpComing Events

Come meet the Renaissance team at these upcoming industry conferences and trade shows. We look forward to connecting, sharing our expertise in nasal drug delivery, and exploring how we can support your next development or manufacturing project.
Press

November 7, 2025

LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Andernach– LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company today announced the successful closing of its acquisition of Renaissance Lakewood, LLC (“Renaissance”), a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms.

READ MORE
Press

October 13, 2025

LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood

Andernach– LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company today announces the acquisition of Renaissance Lakewood, LLC (“Renaissance”), a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms.

READ MORE
Events

July 22, 2025

CPHI Worldwide 2025

Uniting thousands of pharma suppliers and buyers across the full supply chain, CPhI Worldwide is the best platform to source, connect and learn within the industry.

READ MORE
VIEW ALL EVENTS

+$30m

+$30 million in facilities and equipment investments since 2020

1st

Manufacturer of the first FDA approved bi-dose nasal spray drug

370k

Sq. ft. of infrastructure with additional space under construction

+10

cGMP manufacturing suites with additional under construction